INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

Vitamin D3 supplementation up to 5,000 IU/d significantly increased serum 25(OH)D3 and reduced disease activity scores in Crohn's disease patients.

A pilot study evaluated 18 patients with mild-to-moderate Crohn's disease receiving escalating doses of oral vitamin D3 (from 1,000 IU/d up to 5,000 IU/d) for 24 weeks to reach serum levels above 40 ng/ml. Fourteen of the 18 patients required the maximal dose of 5,000 IU/d. Supplementation significantly increased serum 25(OH)D3 levels from 16±10 ng/ml to 45±19 ng/ml (P<0.0001) and reduced unadjusted mean CDAI scores by 112±81 points from 230±74 to 118±66 (P<0.0001). Quality-of-life scores also significantly improved (P=0.0004), while no significant changes in cytokines or other laboratory measures were observed.

Study type
Pilot intervention study
Who was studied
18 patients with mild-to-moderate Crohn's disease (CDAI scores 150-400)
What was measured
Serum 25(OH)D3 levels, CDAI scores, quality of life, bone mineral density, and laboratory measures

THE PAPER

Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients.

Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. Clin Transl Gastroenterol, 2013.

PubMed 23594800 ↗DOI 10.1038/ctg.2013.1 ↗

Gut & microbiomeNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.